Theragenics to Report Fourth Quarter and Year-End 2012 Financial Results Thursday, February 14

Theragenics to Report Fourth Quarter and Year-End 2012 Financial Results Thursday, February 14

BUFORD, Ga.--(BUSINESS WIRE)-- Theragenics Corporation® (NYS: TGX) expects to release fourth quarter 2012 financial results before the market opens on February 14, 2013. Following this release, the Company will host a conference call at 11:00 a.m. Eastern.

To participate in the call, dial 877-407-4019 or 201-689-8337. The call is also being webcast and can be accessed via Theragenics' website, www.theragenics.com. A replay will be available on the website for one month. A phone replay will be available until Midnight, February 21, 2013 by dialing 877-660-6853 or 201-612-7415, and entering the conference ID 408014.


Theragenics Corporation (NYS: TGX) operates two business segments: its surgical products business and its brachytherapy seed business. Its surgical products business (www.cpmedical.com, www.galtmedical.com, www.needletech.com) manufactures and distributes wound closure, vascular access, and specialty needle products. Wound closure products include sutures, needles and other surgical products. Vascular access includes introducers, guidewires and related products. Specialty needles include coaxial, biopsy, spinal and disposable veress needles, access trocars, and other needle based products. The surgical products segment serves a number of markets and applications, including, among others, interventional cardiology, interventional radiology, vascular surgery, orthopedics, plastic surgery, dental surgery, urology, veterinary medicine, pain management, endoscopy, and spinal surgery. Theragenics' brachytherapy business manufactures, markets and distributes "seeds" used primarily in the minimally invasive treatment of localized prostate cancer. The Company's brachytherapy product line includes its palladium-103 TheraSeed® device and its iodine-125 AgX100™ device (www.theragenicsbrachy.com).



Theragenics Corporation
CFO & Treasurer
Frank J. Tarallo, 770-271-0233 or 800-998-8479
or
Manager, Investor Relations
Lisa Rassel, 770-271-0233 or 800-998-8479
www.theragenics.com

KEYWORDS:   United States  North America  Georgia

INDUSTRY KEYWORDS:

The article Theragenics to Report Fourth Quarter and Year-End 2012 Financial Results Thursday, February 14 originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.


Increase your money and finance knowledge from home

Investing in Emerging Markets

Learn to invest in a globalized world.

View Course »

Reading a Stock Quote

Learn to read the ingredients of a stock.

View Course »

Add a Comment

*0 / 3000 Character Maximum